 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Medical News Rapid HIV Antibody Test Wins Approval Ahead of LicensingMarch 24, 2004 The Food and Drug Administration has given approval for OraSure Technologies Inc. to market its OraQuick Rapid HIV-1/2 Antibody test, which allows simultaneous testing for HIV-1 and HIV-2 in blood specimens. Previously, the test was approved only for the detection of the Type 1 form of HIV. The company said it obtained the approval in anticipation of receiving a worldwide, non-exclusive license to certain HIV-2 patents held by Bio-Rad Laboratories Inc., which it expects in the near future. In addition, OraSure is seeking FDA approval of the OraQuick Rapid HIV-1/2 Antibody Test using oral fluid and plasma samples. Wall Street Journal 03.24.04  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
